The tweet was deleted by the author.
But we saved everything 🙂.
CVRx introduces an overview of Barostim therapy through its Chief Medical Officer, Dr. Philip Adamson, MD, MSc, FACC, FESC, FRCP (Ed).
Dr. Adamson explains the key steps involved in the Barostim device procedure and its therapeutic application for patients suffering from heart failure. The review provides insight into how the technology delivers targeted therapy, aiming to improve patient outcomes in the management of chronic cardiac conditions.
View post on X Loading...
Adamson recently discussed his career trajectory and developments in heart failure treatment during a medical podcast appearance. In a separate milestone, CVRx and The Mount Sinai Hospital completed their sixth Barostim implant, highlighting continued procedural adoption at the center (source). These events mark recent touchpoints in Barostim's clinical integration.